<?xml version="1.0" encoding="UTF-8"?>
<p>Losartan is an AT1R blocker that is widely applied in the management of hypertension and to slow down the nephropathy progression in patients with diabetes mellitus. It is a safe drug with infrequent adverse drug events [
 <xref rid="B132-pharmaceuticals-13-00096" ref-type="bibr">132</xref>]. Interestingly, around 50% of hospitalized SARS-CoV patients have developed hypotension during their hospital stay [
 <xref rid="B133-pharmaceuticals-13-00096" ref-type="bibr">133</xref>]. No published clinical data are yet available on hypotension rates among hospitalized (NCT04312009) or non-hospitalized (NCT04311177). SARS-CoV-2 patients; it is thus too early to estimate how safe AT1R blockers in targeting COVID-19 without developing exacerbated hypotension.
</p>
